In this review nutritional characteristics and the health benefits of dietary diacylglycerol are summarized. The global obesity epidemic and our knowledge of its relation to human health have increased research on dietary fat control. Among several approaches, we have focused on the structure of acylglycerols and have studied nutritional functions of diacylglycerol oil in comparison with conventional triacylglycerol oil with the same fatty acid composition. A cooking oil product containing 80% (w/w) or more diacylglycerol has been used in Japan since 1999 as a "Food for Specified Health Use" approved by the Ministry of Health, Labour and Welfare. The approved claims are: (i) Less increase in postprandial triacylglycerol concentrations in the blood and (ii) Less likelihood of being stored as body fat. These effects are probably the result of the unique metabolic characteristics of diacylglycerol because its bioavailability is practically the same as that of triacylglycerol oil. Although studies of its digestion, absorption and metabolic processes are yet to be completed, the ingestion of diacylglycerol oil has been shown to be beneficial in reducing risk factors for life-style related diseases.
ute to the flavor and aroma of foods. However, an excessive intake of fat can result in obesity. The prevalence of obesity has dramatically increased throughout the world over the last decades (for example, see Mokdad et a/., 2003) . Many investigators and surveys have noted the importance of preventing the accumulation of body fat that is associated with certain lif~e-style related diseases. Clinical studies suggest that weight loss in the range of 5-I Oo/o of initial weight can lead to a significant reduction in obesity-related disorders such as heart disease, diabetes mellitus, and hypertension. Although energy restriction and limiting total and saturated f~at intake may be the primary measures for the treatment of obesity, these are diffi~cult to achieve. As a result, numerous studies on dietary fats that infiuence the accumulation of body fat have been conducted.
Dietary diacylglycerol (DAG) is a natural component of var-
ious edible oils and has been used in foods as an emulsifier.
The nutritional characteristics of dietary DAG have been examined in comparison to triacylglycerol (TAG) and the findings in these studies show that DAG, particularly in the 1,3-isofoam, has metabolic characteristics that are distinct from TAG which may produce beneficial effects with regard to the prevention and management of postprandial lipemia and obesity. A cooking oil product containing 800/0 (w/w) or more DAG has been on the market in Japan since 1999 as a "Food for Specih~ed Health Use" as approved by the Ministry of Health, Labour and Welfare. In this article, after brlefly reviewing the strategies for the treatment of obesity, the current state of studies on the nutritional benefits of dietary DAG observed in the clinical trials and mechanistic studies using animal models are outlined. E-mail: noboru.matsu02@kao.co.jp Research directed at agents for the treatment of obesity Changes in dietary habits and exercise are the most popular recommendations for preventing obesity and the metabolic syndrome. However, fats and oils that are good for health in addition to taste are the target of investigators as well. The goal of such studies is the treatment of obesity that resides upstream of various metabolic syndromes such as diabetes, hypertension, hyperlipidemia, and arteriosclerosis (Matsuzawa et a!., 1995; Rimm et a/., 1995; Zimmet et a/., 2001) . Clinical trials have shown the effectiveness of diet intervention (Levy & Heaton, 1993 ; National Institute of Health, National Heart, Lung, and Blood Institute, Obesity Education Initiative, 1998), fat substitutes (Bray et a!., 2002) and medical drugs (Davidson et a/., 1999; Wirth & Krause, 2001 ) on welght loss in overweight or obese subjects. Through these agents, approximately 5-10a/c weight reduction during a treatment period can be readlly achieved.
During the last two decades, f~at-substitutes such as modih~ed starch, cellulose, protein, pectin, dextrose have been developed in attempts to produce a material with the same texture as fat (Wylie-Rosett, 2002 lla chips and other savory snacks in the U.S.
Medlum chain triglycerides (MCT) contalning mainly C8
and C I O fatty acids have recently been reported to reduce body fat in humans (Tsuji et u/., 2001 ) . This and other available data describe the effects of MCT on energy expenditure and satiety and determine their potential efh~cacy as agents in the treatment of human obesity (St-Onge & Jones, 2002) . In relation to MCT, TAG, which contains both medium-and long-acyl chains in a molecule has been shown to reduce the accumulation of body fat in healthy humans (Kasai et a/.. 2003) .
It has recently been reported that conjugated linoneic acid (CLA) consumption improves lipld metabolism, obesity and cancer (Brown & Mclntosh, 2003) . It has been demonstrated that CLA isomers prevent the development of obesity in certain rodent and pig models. This was attributed mainly to the presence of tl~lns-I O, cis-1 2 CLA. However, the ability of CLA to modulate obesity and its saf~ety in humans is currently a matter of debate (Larsen et a/., 2003) .
The health benefits of fish oil, which is rlch in the co-3_ poly- Dietary O)--3-PUFA are also reported to reduce the activities of enzymes involved in fatty acid and TAG synthesis, and to stimulate f'atty acid oxidation and therrnogenesis in the liver, skeletal muscle, and adipose tissue (Jump & Clarke 1999; Ide et ul., 2000; Kabir & Ide, 1996) . Thus, certain dietary oils, possibly due to their fatty acld constituents, show benefi~cial effects on lipid metabolism in varlous organs and thereby on obesity and diabetes. In contrast to these studles that have been mainly focused on the nutrltion of f~atty acids in the TAG molecule, the focus of the study on dietary DAG described below is on glyceride structure. Diacylglycerol has two main health benefi~ts: the suppression of postprandial serum TAG elevation as a short-term effect and the suppression of body fat accumulation as a long-term effect.
Structure of DAG and its occurrence in natural oils and fats was digested to l(3)-MAG, and FFA. Thus, the production of l (_3)-MAG instead of 2-MAG is unique to DAG digestion. The TAG resynthesis pathway In small intestinal epithelial cells includes the 2-MAG pathway and the ct-glycerophosphate (ct-GP) pathway (Fig. 2) , with the former being predominant during the digestlon and absorption of ordinary fat. While 2-MAG Is easily utillzed in the 2-MAG pathway, the reactivity of I (_3)-MAG is lower (Lehner et a/., 1993) . Free glycerol is a substrate for the ot-glycerophosphate pathway, but its contribution to the resynthesis of TAG is small. The incorporation of 14C-labelled linoleic acid into TAG was significantly retarded in the intestinal mucosa of rats in which a DAG oil emulsion, as compared to a TAG oil emulsion, had been infused (Kondo et a/., 2003) .
Murata et u!. reported that the rate of release of resynthesized TAG into intestinal lymph chylomicrons was lower after the adminlstratlon of a DAG emulslon compared to that of a TAG emulsion (Murata et al., 1994) . A slower lymphatic secretion of 14C-labeled triolein after intra-gastric infusion of 14C-1,_3-diolein has also been demonstrated in rats (Yanagita & Ikeda, 200_3) . This may be the result of a decreased rate of reesterih~ca-tion of fatty acids af~ter DAG ingestion. Figure 2 illustrates the metabolic characteristics of DAG as compared with TAG.
In terms of beneficial effects other than nutritional effects, we investigated the stomach emptying time of ingested scrambled eggs cooked with DAG oil. The subjects ingested scrambled eggs cooked with either DAG or TAG oil or no oil. The stomach emptying time was monitored using technetium labeled albumin as a probe in a scintigram. The half emptying time of scrambled eggs cooked with DAG oil was shorter than that cooked with control TAG oil (Yasunaga et a!., 2000) . In the initial phase of our nutritional study of DAG, we hypothesized that DAG might be more easily digested than TAG. This was Less postprandial lipemia in humans after the ingestion of DAG Serum TAG Ievels increase after the ingestion of a meal containing fat and then decrease as TAG, in the form of~ chylomicrons, is cleared from the circulation by enzymatic hydrolysis (Goldberg, 1 996) and receptor-mediated uptake (Eriksson et a!., 1991) . Because of the slow clearance of chylomicron TAG, humans typically spend most of the time in a postprandial hypertriglyceridemic state. Slnce chylomicrons and their cholesterol-rich remnants are implicated in atherogenesis (Zilversmit, 1979; Patsch, 1987; Gianturco & Bradley, 1991; Patsch et u/., 1992; Cohn, 1998) The lower serum TAG Ievels after DAG ingestion may be the result of the slower rate of chylomicron foamation after DAG ingestion compared with that of ingested TAG. Wlth respect to risk factors, DAG has been shown to weaken the postprandial increase in RLP-TAG, which is a more potent risk factor of cardlovascular diseases than whole serum TAG concentrations The lower serum TAG Ievels after DAG ingestion may be the result of a slower rate of chylomicron formation after DAG ingestion compared with that of TAG ingestion as discussed in the previous section.
In addition to postprandial studies, serum TAG in the fasting state has been studied in diabetic patients with hypertriglyceridemia. Type 2 diabetes, abnormal lipid metabolism, hypertension, hyperuricemialgout, arteriosclerotic diseases and fatty liver are known complications of obesity. The impact of diet therapy in a treatment of these life-style related diseases is wldely recognized. A randomized, single-blind, controlled parallel trial was conducted involving type 2 diabetic patients (Yamamoto et a!., 200 1 ) . In this study, the influence of DAG oll consumption by substituting DAG cooking oil for ordinary TAG oll over a three month period on blood lipids was examined in 16 type 2 diabetic patients. The serum TAG Ievels of these patients were consistently increased despite continuous nutritional counseling at an outpatient clinic over a one year period. The primary outcome of this study was a reduction in serum TAG Ievels in the DAG group (from 2.51[t0.75 to l ._52i 0.28 mmol/!, p<0.01) after a three-month treatment. These eft~ects were not associated with an increase in ketone bodies in the serum.
Anti-obesity effects of DAG in animal studies
Experiments were conducted to investigate how DAG consumption affects body weight and fat mass over a long period of time. The efficacy of DAG oil in reducing body weight and fat mass were assessed in both animals and humans.
Animal models have been used extensively to investigate the effects of DAG and to elucidate the mechanism of its action.
When C57BL/6J mice (obesity-and diabetes-prone model mice) were fed a high fat (30a/c, w/w) and sucrose (13a/c, w/w) diet for five months, body weight and body fat (white adipose tissue, WAT) mass increased, compared to a control low fat diet. Insulin and leptin (a peptide product of the OB gene which is associated with obesity in mice as well as in humans) concentrations also increased in these mice. Substituting DAG for TAG prevented the increases in body weight and fat accumulation associated with the high fat and sucrose diet (Fig. 4) (Murase et a!., 200 1 ). Increases in insulin and leptin concentrations were also prevented by substituting TAG with DAG. Mice consuming a DAG diet were able to maintain smaller fat stores suggesting that DAG consumption produced an increase in energy expenditure. This must be proven experirnentally. No differences in total energy or f'ecal fat were noted between the DAG and TAG oil treatments.
Although the mechanisrn for the suppression of body fat accumulation by a DAG diet is yet to be elucidated, it may be due, at least in part, to an increased beta-oxidation in the liver induced by DAG. When food containing 10% DAG was given to rats t~or 2-3 weeks, the enzyme activity relative to fatty acid synthesis in the liver was decreased and that for beta-oxidation of fatty acids was increased (Murata et a!., 1 997). In another experiment with high fat induced obesity model mice (C57BL/ 6J), high DAG diet (for 5 months), as compared to a high TAG diet, increased hepatic acyl-coenzyme A oxidase activity and acyl-coenzyme A synthase mRNA, suggesting a higher capacity for hepatic lipid oxidation (Murase et a!., 2001) . Using the same animal model, Murase and his colleagues showed that, within the first 10 days (before the onset of obesity). DAG consumption stimulated both beta-oxidation and lipid metabolismrelated gene expression, including acyl-CoA oxidase, mediumchain acyl-CoA dehydrogenase and uncoupling protein-2 in the small intestine but not in the liver, skeletal muscle nor brown , 4, 6, 8, 12, 16, 20 , and 24 among subjects in the intent-to-treat sample assigned to diacylglycerol (DAG) oil (n=65) or triacylglycerol (TAG) oil (n=66) treatment groups. Body weights at baseline were 98.0i 1.6 kg and 97.6t 1.8 kg, for the DAG and TAG groups, respectively; Panel B, percent changes from baseline to week 1 2 and week 24 in fat mass among subjects in the intent-to-treat sample assigned to diacylglycerol (DAG) oil (n=49 at week 12 and n=50 at week 24) or triacylglycerol (TAG) oil (n=45 at week 12 and n=46 at week 24). Fat mass at baseline was 35.4t0.9 kg and 34.7i0.9 kg, for the DAG and TAG groups, respectively. For both panels, data are meantSEM and p-values are by repeated measures ANOVA. adipose tissue. This suggested the predominant contribution of intestinal lipid metabolism to the effects of DAG (Murase et al., 2002) .
Repeated DAG vs. TAG consumption reduces body fat in humans Human studies were conducted both in Japan and the United States to observe the chronic effect of DAG consumption. Nagao et al. (2000) conducted a comparative study of DAG oil and TAG oil in 38 healthy Japanese men. Ten grams out of 50 g of fat in the daily diet were replaced with the test oil for a period of 16 weeks in a double-blind parallel study. As shown in Table I , significant decreases were observed in the DAG group compared with the TAG group in body weight, visceral fat, subcutaneous fat and waist circumference. Abdominal fat was evaluated by the area of computed tomography (CT) scan cross-section images.
This Japanese study was expanded using male and female subjects who were categorized as either obese or overweight.
The Chicago Center for Clinical Research (Chicago, IL) conducted a double-blind parallel study in which 131 overweight or obese men and women ingested DAG and TAG diets for 24 weeks (Maki et al., 2002) . In this study, 1 5% of the energy was taken as the test oil under mild hypo-calorie conditions established by subtracting 500-800 kcal from the energy requirement calculated based on body weight, sex, activity level and age. The food products included muffins, crackers, instant soup mix, sugar cookies and granola bars. On the basis of energyrequirement calculations, the amount of test oil corresponded to 1 6 to 45 gld. The decreases in body weight and body fat were significantly greater in the DAG group than in the TAG group (Fig. 5) .
Efficacy of DAG oil incorporated into ordinary meals
The human studies described above were conducted using either fat emulsions as an experimental food or DAG oil products in strictly controlled diet intake. Therefore, it would be of interest to investigate changes in TAG Ievels in the serum or body weight after the ingestion of DAG or TAG that had been incorporated into ordinary meals.
The postprandial response of DAG vs. TAG ingestion was investigated using a mayonnaise type solidified dressing prepared from DAG oil (Takase et al., 2003) or a typical breakfast in which a mayonnaise type DAG ( 10 g DAG oil/60 kg) had been incorporated (Tomonobu et al., 2003) . These studies were double blind placebo controlled cross-over studies in which healthy volunteers had been recruited (average BMI : 25 kg/m2).
The control was regular mayonnaise prepared with TAG with a l 08 fatty acid composition similar to DAG.
Changes in serum TAG Ievels from the initial values were significantly low in the DAG ingestion group compared to the TAG group. Differences were more pronounced for changes in chylomicron TAG and RLP-TAG Ievels.
Long-term s_ tudies conducted on the ad-libitum consumption of DAG oil in adults include a randomized, double blind, controlled, parallel trial, in which _3 1 2 adults were randomized into either a treatment (DAG oil, n= 1_55) or placebo (TAG oil, n= l 57) product group (Koyama et a/., 200_3) . The subjects were in overall good health with a BMI of ;~25 kg/m2 and/or a fasting serum triglyceride level of ;~ 150 mg/dl. They consumed DAG oil for one year without any dietary restrictions and maintained a constant level of physical activity. BMI ~)=0.002) and skinfold thickness (p=0.028) decreased significantly in the DAG group compared to the TAG group.
In conclusion, the long-team consumption of DAG oil when It simply replaces conventional cooking oil may modestly but signlficantly reduce body weight and prevent weight gain as compared with TAG oil consumption, even at a similar calorie intake. Thus, DAG oil may be beneficial for maintaining a healthy body weight.
In additlon to these parallel controlled studies, a two-year monadic study (n=60) (Otsuki et u/., 2003) and a one-year monadic study (n= 1 14) (Katsuragl et a/., 1999) have also been conducted. Similar ef'ficacies were noted and the number of risk factors for subjects who initially had more than three categories of risk factors of metabolic syndrome were significantly decreased in the two-year study. No serious adverse effects with respect to hematology or serum chemistry were noted.
Further applications of DAG
We found signih~cant beneficial effects of DAG over TAG oil by examining the effect of the difference in acylglycerol structure with the same fatty acid composition. (0-3 polyunsaturated fatty acids in foods, such as EPA, DHA and ALA are of interest, as described in the previous section. We pursued the more potent beneficial effects of DAG by incorporating o)-3 PUFA into the DAG structure. In this context, the effects of OL Iinolenic acid-rich diacylglycerol (ALA-DAG) on body fat were investigated in obese model mice C57BL/6J. By incorporating a small amount (1~} wtO70) of ALA-DAG in a diet high in both fat and sucrose (30 wta/o and 13wt%, respectively), body weight gain and visceral fat gain were significantly reduced . These results, obtained by adding a small amount of ALA-DAG, indicate that the anti-obesity function is potentiated by incorporating ALA into the DAG structure, and also indicate the possible effectiveness of using ALA-DAG for the prevention and treatment of life-style related diseases.
In addition to obesity, hypercholesterolemia is another health concern since it has been shown to be associated with various lit~e-style related diseases. Clinical investigations have revealed that the administration of phytosterols in human subjects reduces plasma total cholesterol and LDL cholesterol levels. t~ound that DAG was a better solvent for phytosterols than TAG. They investigated the difference in serum-cholesterol-lowering activities between phytosterols dissolved in DAG and those dispersed in TAG in humans. The administration at a level of 500 mg/day of phytosterols dis-N. MATSUO solved in DAG oil for two weeks signih~cantly reduced total and LDL cholesterol levels from 5.57 to 5.3 1 mmol// (4.7% reduction) and 3.69 to 3.39 mmol// (7.6a/o reduction) respectively, whereas the same amount of phytosterols dispersed in TAG oil had no significant effect (Meguro et a!., 200 1 ). Meguro et a/.
also showed that phytosterols in combination with DAG, as compared to TAG, prevents the development of atherosclerosis via a decrease in total serum cholesterol levels in rabbits (Megro et a!., 2003) . DAG oil containing phytosterols has been on the market In Japan since 200 1 as a "Food for Specified Health Use" approved by the Ministry of Health, Labour and Welf~are .
Conclusion
A cooking oil product containing 80a/c (w/w) or more DAG has been used in Japan since 1999 as a "Food for Specified Health Use" approved by the Ministry of Health, Labour and Although studies of digestion, absorption and metabolic process are yet to be fully elucidated, the ingestion of DAG oil has been shown to be beneficial in reducing risk factors for lifestyle related diseases.
Regarding safety, DAG oil has been evaluated by the Japanese Ministry of Health and We]fare as a "Food for Specih~ed
Health Use" and has also been filed as GRAS (Generally Regarded As Safe) by the FDA in the United States. Clinical and mechanistic studies are still in progress to further confirm the efficacy, its mechanism and to increase the reliability of DAG oil for consumption under various conditions.
